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ABSTRAK
Penelitian ini bertujuan untuk mengkaji pengaruh pengaturan vaksinasi infectious bronchitis
(IB) terhadap produksi telur, kualitas telur, dan tingkat antibodi IB. Perlakuan vaksinasi IB yang
berbeda (kontrol, VicS mata, VicS spray, VicS air, A3 mata, A3 spray, and A3 air) diberikan pada ayamIsa Brown berumur satu hari. Setengah dari jumlah ayam divaksinasi kembali secara rutin pada
umur 22, 30, 38, 46 and 54 minggu, sedangkan sisanya tidak divaksinasi. Hasil menunjukkan bahwa
perlakuan vaksinasi memiliki pengaruh nyata terhadap produksi telur dan kualitas telur (berat telur,
refl ekitivitas cangkang, kekuatan cangkang, ketebalan cangkang, berat albumen, Haugh Units),
dan tingkat antibodi IB, tetapi tidak berpengaruh terhadap persentase cangkang dan warna kuning
telur. Berat telur dan refl ektivitas cangkang kurang baik pada kontrol. Sebaliknya, kekuatan dan
ketebalan cangkang pada kelompok yang diberi vaksin A3 pada air minum memiliki nilai tertinggi.
Revaksinasi secara reguler memiliki efek yang mengganggu produksi dan kualitas telur, tetapi tidak
berpengaruh nyata terhadap tingkat antibodi IB. Kesimpulan penelitian ini bahwa revaksinasi virus
IB secara reguler hanya memberikan keuntungan yang sedikit, jika ayam telah memperoleh vaksinasi
awal yang tepat.
Kata kunci: infectious bronchitis, vaksinasi, revaksinasi, ayam petelur
ABSTRACT
A research was conducted to investigate the eff ects of vaccination protocols for Infectious
Bronchitis (IB) on egg production, egg quality, and IB antibody titres of laying hens. Diff erent ini-
tial vaccination (Control, VicS eye, VicS spray, VicS water, A3 eye, A3 spray, and A3 water) for IB
were administered to day-old Isa Brown hens.  Half the hens were revaccinated regularly during lay
whereas the other hens were not vaccinated. Results showed that initial vaccination treatment had
signifi cant eff ects on hen day egg production and egg quality of egg weight, shell refl ectivity, shell
breaking strength, shell thickness, albumen height, Haugh Units, and IB antibody titre levels, but
had no eff ect on percentage of shell and yolk colour. Egg weight and shell refl ectivity were less fa-
vourable in the control hens.  In contrast, shell breaking strength and shell thickness were highest
for the group that initially received A3 vaccine in water. However, regular revaccination had some
deleterious eff ects on egg production and egg quality. There were no signifi cant eff ects of revaccina-
laying hens for IB virus, since they had received appropriate initial vaccination.
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INTRODUCTION
Infectious bronchitis (IB) is a highly infectious and
contagious respiratory virus disease which has been
widespread and identifi ed all over the world. The infec-
tion has a great economical eff ect on the layer industry,
because it aff ects on egg production. Besides respiratory
lesions, early exposure to IB virus causes extensive da-
mage to wide range of various epithelial surfaces of the
body both in layers (Cavanagh, 2003). Chousalkar et al.
(2007) reported IB virus aff ected on Harderian gland,
tracheal mucosa, kidney, and region of oviduct such
as the magnum, tubular shell gland, and shell gland
pouch of laying hens. It is associated with nephritis and
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respiratory distress in broilers and with the so-called
“false layer syndrome” and drops in egg production
in breeders and layers. It is therefore causing major
economic problems in IB-vaccinated fl ocks (de Wit et al.,
2011). Butcher & Miles (2001) mentioned that for laying
hens IB not only aff ects egg production but also egg
shell and internal egg quality.
The syndrome may cause partial or complete failure
of the oviduct to develop, and in laying period, hens will
not ovulate normally. Poor egg specifi c gravity, reduced
shell thickness, misshapen eggs, pale shell pigmentation,
watery albumen that leads to greatly reduced Haugh
Unit (HU) values are a refl ection of dysfunctional or
damaged oviducts (Butcher & Miles, 2001). Therefore,
it is relevant to investigate the suitability of the current
vaccines in protecting birds in the fi eld.
Since there is no appropriate drug therapy for
controlling this disease, increasing the resistance of
birds by vaccination is still the cornerstone of strategy
for protecting chickens from IBV infection (Lister, 2001).
Although no homologous vaccine was available until
very recently, some success is reported in controlling its
eff ects using currently available IB vaccines (de Wit et al.,
2011). Various IB virus serotypes are used as commercial
Connecticut, Holland, Arkansas, Florida and JMK. Both
live and inactivated virus vaccines are used in broilers
and for the initial vaccination of breeders and layers
(Cavanagh & Gelb Jr., 2008).
The most common strains of IB virus vaccine used
by the egg industry were Webster’s VicS (Fort Dodge)
and A3 (Fort Dodge). Some producers use only one
strain (usually VicS) whereas others alternate the two
strains during the rearing phase. Routes of vaccine
administration vary, with coarse spray at the hatchery,
and either coarse spray or in water vaccination for sub-
sequent vaccinations, being the norm. Some producers
do not revaccinate for IB once the birds have come into
lay. However, increasingly, poultry veterinarians are
recommending regular revaccination, usually every 8
weeks throughout lay. Results from a previous experi-
ment, using Webster’s VicS IB vaccine strain with ISA
brown cockerels, indicated that vaccination at either
day-old or two weeks of age, by eye drop, coarse spray
or water vaccination, protected birds against the eff ects
of exposure to T strain IB virus.
The objectives of this experiment were to determine
the eff ects of diff erent initial vaccination protocols
(diff erent virus strains of vaccine and routes of vaccine
administration) for IB and regular revaccination every
8 weeks during lay, as compared with no revaccination
beyond 14 weeks of age on hen day egg production, egg
quality and IB antibody titres  of  ISA Brown laying hens.
MATERIALS AND METHODS
Chickens and Management
Day-old-ISA Brown layers (623 birds) were
transferred to isolation pens. The birds were reared
according to standard commercial practice. Seven (7)
isolation fl oor sheds (2 x 3 m2) were used. After being
reared in isolation pens for 15 weeks, all birds were
transferred to two poultry isolation sheds equipped
with 3-bird commercial-style cages. Each cage had one
feeder and at least two accessible drinking nipples. The
birds were supplied with feed and drinking water ad
lib. A pre-layer diet (pullet grower with added calcium)
was fed until birds had reached 5% production, after
which birds received a standard commercial layer mash.
Natural light was applied until birds had reached 5% lay
or 18 weeks of age, after which birds received 14 hours
light (6 am to 8 pm). The light phase was increased by
30 minutes per week. Clinical signs and mortality were
recorded if observed and all mortalities autopsied.
Experimental Design and Measurements
There were seven initial experimental groups set
up at day-old, each of 89 birds: control (no vaccination),
VicS eye (VicS vaccine by eye drop at day-old), VicS
spray (VicS by coarse spray at day-old), VicS water
(VicS in water at day-old), A3 eye (A3 vaccine strain
by eye drop at day-old), A3 spray (A3 by coarse spray
at day-old), A3 water (A3 in water at day-old). The
Control group remained unvaccinated. At 14 weeks of
age, all birds (including the control birds which had
not been vaccinated previously) were revaccinated with
VicS vaccine strain by eye drop. At 15 weeks of age,
all birds were transferred to the two poultry isolation
sheds.  One-half of the birds from each treatment group
were allocated to each shed, 2 birds per cage (a total of
14 groups). The birds in one shed (seven groups) were
revaccinated every 8 weeks with VicS vaccine strain by
coarse spray, whereas the birds in the other shed (the
other seven groups) were not revaccinated beyond 14
weeks of age. For all vaccinated groups, the vaccines
used were Webster’s VicS (Fort Dodge) and A3 (FortDodge) strains of IB virus. For regular revaccination,
VicS vaccine strain was used and administered by coarse
spray. Revaccination of the regularly revaccinated
groups was conducted at 22, 30, 38, 46, and 54 weeks of
age.
Egg production, average egg weight and the
external appearance of the eggs were recorded daily.
Percentages of egg production were calculated as hen-
day production. On the day of lay, 30 eggs from each
treatment group were weighed using an O’haus Balance.
Every 4 weeks, 21 eggs from each initial vaccination
treatment group from each shed were collected for egg
and eggshell quality measurements. Shell breaking
strength (Newton), shell refl ectivity (%), egg weight
(g), albumen height (mm), Haugh Units (HU), yolk
colour (Roche score), percentage shell (shell weight/egg
weight, %) (using TSS egg analyser) and shell thick-
ness (µm) (using a digital micrometer) were measured.
Measurements were conducted after all eggs were
stabilized in the cool room for 24 hours and were deter-
mined at 20, 24, 28, 32, 36, 40, 44, 48, 52 and 56 weeks
of age. Heparinised blood samples were centrifuged in a
Hearaeus Christ centrifuge at 3000 RPM for 10 minutes
to separate the blood plasma, and the blood plasma was
stored frozen at –20 oC for before analysis. IB antibody
titres were measured in samples of plasma using a Flock
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Check Infectious Bronchitis Virus Antibody Test Kit
(IDEXX Laboratories).
Statistical Analysis
Analysis of variance was used to test the eff ect of
initial vaccination treatment and regular revaccination
on each measured parameter. Fisher’s protected LSD
was utilized to separate means when signifi cant eff ects
were observed. Statements of statistical signifi cance
were based on P<0.05 unless otherwise indicated.
RESULTS AND DISCUSSION
Hen-day Egg Production
Initial vaccination treatment had signifi cant eff ect
on hen-day egg production from 20 to 56 weeks (Table
1). Production was slightly lower for the control and A3
course spray initial vaccination treatment groups. There
was eff ect of regular revaccination on hen-day egg pro-
duction between 20 and 56 weeks of age, with the egg
production of regularly revaccinated birds being lower
than those without revaccinated (Table 2 and Figure
1). Egg production during this period averaged 88.1
eggs/100 hens/day in the birds that were not revacci-
nated and 86.6 eggs/100 hens/day in the birds that were
revaccinated regularly every 8 weeks from 22 weeks to
54 weeks. Some researchers reported that applying live
IB vaccines in fl ocks approaching peak production may
produce a 10% fall in egg production which usually
remained depressed for about three weeks. Whatever
live vaccine is used, the application is a very critical step.
IBV virus is a sensitive virus that can be inactivated eas-
ily (Cavanagh & Gelb, 2008), which may result in inad-
equate effi  cacy of the vaccination under fi eld conditions
(Jackwood et al., 2009; de Wit et al., 2010).
The major goal of a vaccination program is to pre-
vent disease and economic losses associated with infec-
tion by disease agents. The vaccine may be applied by
eye drop or nasal drop, spray or drinking water routes
and it is essential that a high percentage of the birds
Group
HD egg
production
(%)
Egg
weight
(g)
Shell
refl ectivity
(%)
Shell break-
ing strength
(Newton)
Percentage
shell
(%)
Shell thick-
ness
(µm)
Albumen
height
(mm)
Haugh
Units
(HU)
Yolk colour
(Roche
score)
Control 85.1±0.80b 56.8±0.30b 34.2±0.30a 42.2±0.40ab 10.10±0.05 432.8±1.70b 7.65±0.07a 87.0±0.40a 11.21±0.10
VicS, eyedrop at
day-old
87.5±0.80a 60.1±0.40a 33.7±0.20ab 42.1±0.40b 10.07±0.05 431.2±1.70b 7.52±0.07ab 85.8±0.50b 11.25±0.10
VicS, coarse
spray at day-old
88.5±0.70a 60.1±0.40a 34.2±0.30a 41.9±0.40bc 10.07±0.05 430.8±1.60b 7.47±0.06b 85.5±0.50b 11.24±0.10
VicS, in water at
day-old
87.8±0.70a 59.9±0.30a 33.3±0.20b 41.4±0.40bc 10.06±0.04 432.9±1.50b 7.29±0.07cd 84.4±0.50c 11.23±0.10
A3, eyedrop at
day-old
87.7±0.80a 60.3±0.40a 32.5±0.30c 40.9±0.40c 10.03±0.05 431.3±1.60b 7.41±0.06bc 85.0±0.40bc 11.32±0.10
A3, coarse spray
at day-old
86.0±0.80b 60.3±0.30a 33.1±0.30bc 41.4±0.40bc 10.02±0.05 433.1±1.80b 7.23±0.06d 84.1±0.40c 11.21±0.10
A3, in water at
day-old
88.6±0.70a 60.2±0.30a 33.2±0.30b 43.2±0.40a 10.20±0.05 438.2±1.50a 6.94±0.06e 82.3±0.40d 11.14±0.10
Tabel 1. Means of hen day egg  production and egg qualities at 20-56 weeks of laying hens treated by initial vaccination
Note: Means in the same column with diff erent superscript diff er signifi cantly (P<0.05).
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Figure 1. Production (eggs/100 hens/day) from 16 to 56 weeks of age in revaccinated hens (   ) regularly every 8 weeks during lay or
not revaccinated (   )
16   18  20 22   24   26  28   30  32  34   36 38   40 42  44  46  48   50  52   54  56
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receive a required dose of the vaccine in the right tissue
(Cook et al., 2008). Initial vaccination treatment of IB had
a number of eff ects on the subsequent performance of
the fl ock, during the laying phase. The treatment given
to the control group, which was no vaccination until
VicS vaccine strain was administered at 14 weeks of
age, had a number negative eff ects on the birds during
lay.  Production was lower for the control birds at 20-56
weeks than for the other groups except the A3 coarse
spray group.
shell thickness being 5 microns greater for the birds
that were not revaccinated regularly (Table 2). The birds
that were revaccinated regularly during lay had thinner
shells in every initial vaccination treatment except for
VicS eye drop and A3 coarse spray group. A3 in water
and not revaccinated was the thickest and A3 eye drop
and revaccinated regularly the thinnest. There was sig-
nifi cant diff erence between initial vaccination treatment
groups on albumen height (Tables 1), with albumen
quality being highest for the control and lowest for the
A3 water group. However, there was no signifi cant
diff erence in albumen quality between birds that were
regularly revaccinated during lay, and those that were
not (Table 2).
There was a signifi cant diff erence among initial
vaccination treatment groups for Haugh Units (Table
1), with Haugh Units being highest for the control and
lowest for the A3 water group. There was a signifi cant
eff ect of regular revaccination for Haugh Units, being
lower for those that were revaccinated regularly during
lay than those that were not. The birds that were revac-
cinated regularly during lay had lower Haugh Units
in every initial vaccination treatment except for VicS
coarse spray and A3 in water groups. However, there
was no signifi cant eff ect of initial vaccination treatment
or regular revaccination during lay on percentage yolk
colour. All yolk colour scores were at optimal levels, by
egg commercial standards.
Initial vaccination at day-old with A3 strain IB virus
resulted in both advantages and disadvantages during
lay. Shell colour (as shell refl ectivity) was darker in the
A3 groups than for the control and VicS groups. Shell
thickness was highest in the A3 water group. Eff ects on
shell breaking strength were variable, with the A3 water
group having the highest shell breaking strength but
the A3 eye group having the lowest. However, albumen
quality was lowest for the A3 water group.
Regular revaccination during lay (at 22, 30, 38,
46, and 54 weeks of age) had no overall eff ect on shell
refl ectivity (shell colour), albumen height, and yolk
colour. However, in general, egg production, eggshell
quality (shell breaking strength, percentage shell, shell
thickness), and egg internal quality (Haugh Units) were
lower in the birds that were revaccinated regularly
during lay. The negative eff ects of regular revaccination
are most likely the result of the response of the birds to
exposure to IB virus, even though as a vaccine strain.
Furthermore, the negative eff ects of regular revaccina-
tion on egg and eggshell quality may indicate a negative
eff ect of IB vaccine on the oviduct agrees with Cavanagh
(2003) and Choulsalkar et al. (2007). Roberts (2004)
reviewed factors that aff ect egg shell quality and egg
internal quality including: the strain and age of hen, pro-
duction system, nutrition, induced moult, storage, stress,
and diseases. Infectious bronchitis has been reported
to cause egg shells to be paler in colour and sometimes
wrinkled in appearance.
The results above suggest that in fl ocks, whose
antibody levels are high, no increased protection may
be achieved by revaccination during lay and an adverse
eff ect upon egg production and quality can be induced
Table 2. Hen day production and egg qualities of laying hens
due to revaccinated regularly or not revaccinated dur-
ing lay
Egg protein and
egg quality Revaccinated
Not
revaccinated
Hen day egg produc-
tion (%)
  86.60±0.40b   88.10±0.40a
Egg weight (g)   60.40±0.20a   59.40±0.20b
Shell refl ectivity (%)   33.40±0.10   33.40±0.01
Shell breaking
strength (Newton)
  41.20±0.20b   42.50±0.20a
Percentage shell (%)     9.98±0.02b   10.18±0.03a
Shell thickness (µm) 430.40±0.90b 435.30±0.90a
Albumen height (mm)     7.34±0.04     7.38±0.03
Haugh Units (HU)   84.50±0.30b   85.20±0.20a
Yolk colour (Roche
score)
  11.24±0.03   11.22±0.03
Note: Means in the same row with diff erent superscript diff er signifi -
cantly (P<0.05).
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Egg and Egg Quality
Egg weight was lower for the initial control vaccina-
tion group (birds not vaccinated at all until 14 weeks of
age) than for all other treatments (Table 1). Egg weight
was higher overall in the birds that were revaccinated
regularly than those without revaccinated beyond 14
weeks of age (Table 2). There were signifi cant diff erences
among initial vaccination treatments on shell refl ectivity,
with shell colour being lightest for the control and VicS
groups (Table 1). The groups vaccinated initially with A3
had generally darker shells. Shell colour was not aff ected
by regular vaccination (Table 2).
Initial vaccination treatment group had a signifi cant
eff ect on shell breaking strength. There was a signifi cant
eff ect of regular revaccination with breaking strength
being slightly higher for the eggs produced by the birds
that were not revaccinated regularly (Table 2). Animal
received eyedrop vaccine and water had a lower shell
breaking compared to that of the other groups.
There was a signifi cant eff ect of initial vaccination
treatment on shell thickness (Table 1). Shell thickness
was higher in the group that received A3 in water ini-
tially than for all other groups. There was a signifi cant
eff ect of regular revaccination on shell thickness with
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by the vaccine itself. Poor egg specifi c gravity, reduced
shell thickness, misshapen eggs, pale shell pigmentation,
watery albumen that leads to greatly reduced Haugh
Unit (HU) values are a refl ection of dysfunctional or
damaged oviducts (Butcher & Miles, 2001). Although
the use of live and killed vaccines which promote a wide
spectrum of antibody is suggested, however, the use of
live vaccines on farms where laying birds are present
should be avoided. Revaccination with mild IB virus
vaccine during lay needs to be justifi ed on the grounds
that the optimum egg production is obtained in fl ocks
where IB is not circulating or introduced, although the
role of IBV in cases of egg production drop or poor egg-
shell quality is unknown (Ignjatovic et al., 2001).
IB Antibody Titre Levels
There were signifi cant eff ects of initial vaccination
treatment on IB antibody titre levels that measured at
4, 6, and 16 weeks of age. IB antibody titre was higher
for A3 eyedrop than all peaks and control, but there
were no diff erent with A3 coarse and A3 water (Table
3). However, there were not signifi cant eff ects of revac-
cination on IB antibody titre levels until 49 weeks of
measurements. The titre levels of all groups increased
signifi cantly from 4 weeks to 16 weeks of age.  The con-
trol group of birds remained negative for IB antibodies
until they were vaccinated with VicS at 14 weeks of age
(Figure 2).
Even though there was no diff erent of IB antibody
titre level between revaccinated regularly hens and
not revaccinated hens, the titre levels of all groups in-
creased signifi cantly from 4 weeks to 16 weeks of age.
The results indicated the increase in immune response
following vaccination. The increase of antibody titres is
an indication that the vaccination has been carried out
carefully and correctly (Cook et al., 1999).
Since there is no appropriate drug therapy for con-
trolling this disease, vaccination is still the main strategy
for protecting chickens from IB virus infection (Lister,
2001).  For the initial vaccination of breeders and layers,
and also for broilers, both live and inactivated virus vac-
cines are applicable. However, at point of lay in breeders
and layers inactivated oil-emulsion vaccines are used in
used in poultry industry. Commercial mass application
methods of IB vaccination include coarse spray, aerosol,
and drinking water (Cavanagh & Gelb Jr., 2008). It ap-
pears that good immunity can be achieved when vaccine
is administered via a range of diff erent routes, pro-
vided that each bird receives an adequate vaccine dose.
Landman (2002) reported that protection provided by
live and inactivated virus vaccination against challenge
with the virulent nephropathogenic infectious bronchitis
virus (NIBV) strain PA/Wolgemuth/98 was assessed.
Even though, serum IBV enzyme-linked immunosorbent
assay antibody geometric mean titers (GMTs) after vac-
were low, ranging from 184 to 1354, and prior to NIBV
challenge at 10 wk of age.
Live IB vaccines are generally recognized as pro-
viding good initial protection against infection, but in
trying to provide immunity throughout the laying pe-
riod, revaccination of hens during lay is recommended.
Continual use of live vaccines complicates diagnosis
since no simple diagnostic tool can diff erentiate in a
fi eld from a vaccine strain (Ignjatovic & Sapats, 2000).
Studies of molecular epizootiology reveal a strong prob-
ability that vaccination may lead to the spread of a vac-
Tabel 3. IB antiboby titres in 4-16 weeks of age of hens treated
with initial vaccination
Note: Means in the same column with diff erent superscript diff er sig-
nifi cantly (P<0.05).
IB antibody titres
Control    743±277c
VicS, eyedrop at day-old    825±228c
VicS, coarse spray at day-old 1,110±248bc
VicS, in water at day-old    808±218c
A3, eyedrop at day-old 2,015±445a
A3, coarse spray at day-old 1,195±317abc
A3, in water at day-old 1,756±429ab
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Figure 2. IB antibody titres of revaccinated hens regularly every 8 weeks (A) and not revaccinated hens during lay (B), control: -♦-, Vics
eye: -■-, Vics spray: -▲-, Vics water: -×-, A3 eye: -☼-, A3 spray: -●-, A3 water: -ǀ-
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cine virus, causing various disease manifestations and a
confusing epizootiological situation in a poultry popula-
tion (Farsang et al., 2002). Nephropathogenic infectious
bronchitis (NIB) was diagnosed in 28 infectious bron-
chitis virus (IBV)–vaccinated commercial chicken fl ocks
in Pennsylvania that show minimal respiratory disease
signs in broilers, egg production and shell quality de-
clined in layers (Ziegler et al., 2002). All vaccines such as
VicS, A3, Steggles, Inghams, and others that have been
used in poultry industry are considered to give good
protection against several virulent, nephritis-inducing
viruses of diff erent sub-types.  However, their safety and
CONCLUSION
ing laying hens for IB virus, since they have received
appropriate initial vaccination.
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